Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
SMLR Stock Forecast 2026-2027
$21.37
Current Price
$326.64M
Market Cap
Buy 3
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to SMLR Price Targets
+302.4%
To High Target of $86.00
+180.8%
To Median Target of $60.00
+138.7%
To Low Target of $51.00
SMLR Price Momentum
+3.4%
1 Week Change
+33.3%
1 Month Change
-61.9%
1 Year Change
+39.8%
Year-to-Date Change
-67.9%
From 52W High of $66.50
+43.6%
From 52W Low of $14.89
📊 TOP ANALYST CALLS
Did SMLR Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Semler is one of their latest high-conviction picks.
Latest SMLR Stock Price Targets & Analyst Predictions
Based on our analysis of 7 Wall Street analysts, SMLR has a bullish consensus with a median price target of $60.00 (ranging from $51.00 to $86.00). The overall analyst rating is N/A (N/A/10). Currently trading at $21.37, the median forecast implies a 180.8% upside. This outlook is supported by 3 Buy, 0 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Mark Palmer at Benchmark, projecting a 302.4% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
SMLR Analyst Ratings
3
Buy
0
Hold
0
Sell
SMLR Price Target Range
Low
$51.00
Average
$60.00
High
$86.00
Current: $21.37
Latest SMLR Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for SMLR.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Sep 23, 2025 | Benchmark | Mark Palmer | Buy | Maintains | $86.00 |
| Sep 19, 2025 | Maxim Group | Matthew Galinko | Buy | Maintains | $80.00 |
| Aug 6, 2025 | Cantor Fitzgerald | Brett Knoblauch | Overweight | Maintains | $60.00 |
| Jul 28, 2025 | Cantor Fitzgerald | Brett Knoblauch | Overweight | Initiates | $61.00 |
| Jul 9, 2025 | Maxim Group | Matt Galinko | Buy | Initiates | $95.00 |
| Jul 8, 2025 | Benchmark | Mark Palmer | Buy | Initiates | $101.00 |
| Jan 24, 2025 | Lake Street | Brooks O'Neil | Buy | Maintains | $71.00 |
| Nov 2, 2022 | B. Riley Securities | Marc Wiesenberger | Neutral | Downgrade | $45.00 |
| May 3, 2022 | B. Riley Securities | Marc Wiesenberger | Buy | Maintains | $60.00 |
| Mar 7, 2022 | B. Riley Securities | Marc Wiesenberger | Buy | Maintains | $70.00 |
| Nov 2, 2021 | B. Riley Securities | Marc Wiesenberger | Buy | Maintains | $145.00 |
| Oct 26, 2021 | B. Riley Securities | Marc Wiesenberger | Buy | Maintains | $175.00 |
| May 4, 2021 | B. Riley Securities | Marc Wiesenberger | Buy | Maintains | $151.00 |
| May 4, 2021 | B. Riley FBR | Buy | Maintains | $N/A | |
| Jun 23, 2020 | B. Riley FBR | Buy | Initiates | $N/A | |
| Jun 23, 2020 | B. Riley Securities | Buy | Initiates | $N/A | |
| Jul 29, 2015 | H.C. Wainwright | Initiates | $N/A | ||
| Jul 29, 2015 | HC Wainwright & Co. | Initiates | $N/A | ||
| Jun 5, 2014 | Aegis Capital | Buy | Initiates | $N/A |
Semler Scientific Inc. (SMLR) Competitors
The following stocks are similar to Semler based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Semler Scientific Inc. (SMLR) Financial Data
Semler Scientific Inc. has a market capitalization of $326.64M with a P/E ratio of 3.9x. The company generates $36.96M in trailing twelve-month revenue with a 130.8% profit margin.
Revenue growth is -44.6% quarter-over-quarter, while maintaining an operating margin of -72.0% and return on equity of +17.7%.
Valuation Metrics
Market Cap
$326.64M
Enterprise Value
$414.59M
P/E Ratio
3.9x
PEG Ratio
0.1x
Price/Sales
8.4x
Growth & Margins
Revenue Growth (YoY)
-44.6%
Gross Margin
+91.5%
Operating Margin
-72.0%
Net Margin
+130.8%
EPS Growth
+201.3%
Financial Health
Cash/Price Ratio
+3.1%
Current Ratio
2.0x
Debt/Equity
25.3x
ROE
+17.7%
ROA
-1.0%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Semler Scientific Inc. (SMLR) Business Model
About Semler Scientific Inc.
What They Do
Develops innovative medical diagnostic products.
Business Model
Semler Scientific generates revenue by marketing advanced diagnostic technologies, primarily through its flagship product, QuantaFlo, which aids in the early identification of peripheral arterial disease (PAD). The company targets medical practitioners and healthcare providers, offering user-friendly and cost-effective solutions that enhance diagnostic efficiency and patient care.
Additional Information
Operating within the healthcare technology sector, Semler Scientific addresses a critical market need for early detection of serious health conditions. Its innovative approach positions the company for potential growth and impact within the medical field, highlighting its significance in preventative healthcare.
Company Information
Sector
Healthcare
Industry
Medical Devices
Employees
79
CEO
Dr. Douglas Murphy-Chutorian M.D.
Country
United States
IPO Year
2014
Website
www.semlerscientific.comSemler Scientific Inc. (SMLR) Latest News & Analysis
Latest News
Quick Summary
Former Louisiana Attorney General Charles C. Foti, Jr. has been mentioned in a news release dated December 12, 2025. Further details on his current role or activities were not provided.
Why It Matters
The mention of a former Attorney General indicates potential legal developments or regulatory changes that could impact businesses and investments in Louisiana and beyond.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
Wohl & Fruchter LLP is investigating the fairness of Semler Scientific's proposed all-stock merger with Strive Asset Management, where Semler shareholders would receive 21.05 shares of Strive per Semler share.
Why It Matters
The investigation by Wohl & Fruchter LLP into Semler's merger with Strive may indicate potential issues with the deal's fairness, impacting stockholder confidence and market perception.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Crypto's Hottest Trade Crumples
1 month ago
Quick Summary
In 2025, the trend of digital asset treasuries (DATs) is reversing, with US and Canadian-listed companies seeing a median stock price decline of 45% this year.
Why It Matters
A 45% decline in stock prices of digital asset treasuries signals weakening investor confidence in crypto, potentially impacting market sentiment and valuations.
Source: Bloomberg Markets and Finance
Market Sentiment:
Negative
Quick Summary
A class action lawsuit has been filed against Semler Scientific, Inc. (NASDAQ: SMLR) and its officers, as announced by law firm Bronstein, Gewirtz & Grossman, LLC.
Why It Matters
A class action lawsuit against Semler Scientific may lead to financial liabilities, regulatory scrutiny, and potential stock price volatility, impacting investor confidence and future performance.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Levi & Korsinsky, LLP has filed a class action lawsuit for Semler Scientific, Inc. (NASDAQ: SMLR) investors, alleging securities fraud impacting shares from March 10, 2021, to April 15, 2025.
Why It Matters
A class action lawsuit against Semler Scientific for alleged securities fraud may lead to financial losses for investors and could impact the company's stock performance and reputation.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
A class action lawsuit has been filed against Semler Scientific, Inc. (NASDAQ: SMLR). Affected investors are encouraged to contact Pomerantz LLP for more information.
Why It Matters
A class action lawsuit against Semler Scientific may indicate potential legal risks and financial instability, affecting share prices and investor confidence in the company.
Source: PRNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About SMLR Stock
What is Semler Scientific Inc.'s (SMLR) stock forecast for 2026?
Based on our analysis of 7 Wall Street analysts, Semler Scientific Inc. (SMLR) has a median price target of $60.00. The highest price target is $86.00 and the lowest is $51.00.
Is SMLR stock a good investment in 2026?
According to current analyst ratings, SMLR has 3 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $21.37. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for SMLR stock?
Wall Street analysts predict SMLR stock could reach $60.00 in the next 12 months. This represents a 180.8% increase from the current price of $21.37. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Semler Scientific Inc.'s business model?
Semler Scientific generates revenue by marketing advanced diagnostic technologies, primarily through its flagship product, QuantaFlo, which aids in the early identification of peripheral arterial disease (PAD). The company targets medical practitioners and healthcare providers, offering user-friendly and cost-effective solutions that enhance diagnostic efficiency and patient care.
What is the highest forecasted price for SMLR Semler Scientific Inc.?
The highest price target for SMLR is $86.00 from Mark Palmer at Benchmark, which represents a 302.4% increase from the current price of $21.37.
What is the lowest forecasted price for SMLR Semler Scientific Inc.?
The lowest price target for SMLR is $51.00 from at , which represents a 138.7% increase from the current price of $21.37.
What is the overall SMLR consensus from analysts for Semler Scientific Inc.?
The overall analyst consensus for SMLR is bullish. Out of 7 Wall Street analysts, 3 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $60.00.
How accurate are SMLR stock price projections?
Stock price projections, including those for Semler Scientific Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: January 15, 2026 4:19 AM UTC